Premium
Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE ‐013
Author(s) -
Ribrag Vincent,
Avigan David E.,
Green Damian J.,
WiseDraper Trisha,
Posada Juan G.,
Vij Ravi,
Zhu Ying,
Farooqui Mohammed Z. H.,
Marinello Patricia,
Siegel David S.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15888
Subject(s) - pembrolizumab , medicine , lenalidomide , oncology , multiple myeloma , cohort , refractory (planetary science) , neutropenia , immunotherapy , chemotherapy , cancer , astrobiology , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom